These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 3536089)
1. Minimal residual neoplastic disease--concept, pathogenesis, and supplementary therapeutic possibilities. Prindull G Cancer Treat Rev; 1986 Sep; 13(3):177-94. PubMed ID: 3536089 [No Abstract] [Full Text] [Related]
2. Metastasis awakening: the challenges of targeting minimal residual cancer. Polzer B; Klein CA Nat Med; 2013 Mar; 19(3):274-5. PubMed ID: 23467237 [No Abstract] [Full Text] [Related]
3. [Tumor dormancy and identification of therapeutic targets]. Li CF; Cao S; Meng SD Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889 [TBL] [Abstract][Full Text] [Related]
4. Cancer. Fusion for moving. Clawson GA Science; 2013 Nov; 342(6159):699-700. PubMed ID: 24202164 [No Abstract] [Full Text] [Related]
5. Cancer stem cells and chemoresistance: The smartest survives the raid. Zhao J Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500 [TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells: a step toward the cure. Boman BM; Wicha MS J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956 [No Abstract] [Full Text] [Related]
7. Minimal residual disease in solid neoplasia: New frontier or red-herring? Mordant P; Loriot Y; Lahon B; Castier Y; Lesèche G; Soria JC; Massard C; Deutsch E Cancer Treat Rev; 2012 Apr; 38(2):101-10. PubMed ID: 21612875 [TBL] [Abstract][Full Text] [Related]
8. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications. Wong RS; Cheong SK Malays J Pathol; 2012 Dec; 34(2):77-88. PubMed ID: 23424769 [TBL] [Abstract][Full Text] [Related]
9. Dormant Cells: The Original Cause of Tumor Recurrence and Metastasis. Li J; Jiang E; Wang X; Shangguan AJ; Zhang L; Yu Z Cell Biochem Biophys; 2015 Jun; 72(2):317-20. PubMed ID: 25556072 [TBL] [Abstract][Full Text] [Related]
10. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Mitra A; Mishra L; Li S Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923 [TBL] [Abstract][Full Text] [Related]
11. [The importance of stem cells in the initiation and development of cancer]. Pergoł P; Nowak-Stepniowska A; Drela K; Padzik-Graczyk A Postepy Biochem; 2013; 59(1):45-52. PubMed ID: 23821942 [TBL] [Abstract][Full Text] [Related]
12. Isolation, identification, and characterization of cancer stem cells: A review. Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667 [TBL] [Abstract][Full Text] [Related]
13. Theoretical considerations regarding the early use of adjuvant chemotherapy. Goldie JH; Coldman AJ Recent Results Cancer Res; 1986; 103():30-5. PubMed ID: 3738195 [No Abstract] [Full Text] [Related]
14. Tumor dormancy and cancer stem cells: two sides of the same coin? Kleffel S; Schatton T Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979 [TBL] [Abstract][Full Text] [Related]
15. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion. Wang H; Stoecklein NH; Lin PP; Gires O Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128 [TBL] [Abstract][Full Text] [Related]
17. Stem-cell origin of metastasis and heterogeneity in solid tumours. Tu SM; Lin SH; Logothetis CJ Lancet Oncol; 2002 Aug; 3(8):508-13. PubMed ID: 12147437 [TBL] [Abstract][Full Text] [Related]